These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27980877)

  • 1. Suprachoroidal Corticosteroid Administration: A Novel Route for Local Treatment of Noninfectious Uveitis.
    Goldstein DA; Do D; Noronha G; Kissner JM; Srivastava SK; Nguyen QD
    Transl Vis Sci Technol; 2016 Dec; 5(6):14. PubMed ID: 27980877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial.
    Yeh S; Khurana RN; Shah M; Henry CR; Wang RC; Kissner JM; Ciulla TA; Noronha G;
    Ophthalmology; 2020 Jul; 127(7):948-955. PubMed ID: 32173113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suprachoroidal Injection of Triamcinolone- Review of a Novel Treatment for Macular Edema Caused by Noninfectious Uveitis.
    Price KW; Albini TA; Yeh S
    US Ophthalmic Rev; 2020; 13(2):76-79. PubMed ID: 34322164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS: A Randomized, Phase 2 Study (DOGWOOD).
    Yeh S; Kurup SK; Wang RC; Foster CS; Noronha G; Nguyen QD; Do DV;
    Retina; 2019 Oct; 39(10):1880-1888. PubMed ID: 30113933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA).
    Henry CR; Shah M; Barakat MR; Dayani P; Wang RC; Khurana RN; Rifkin L; Yeh S; Hall C; Ciulla T
    Br J Ophthalmol; 2022 Jun; 106(6):802-806. PubMed ID: 33547034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis.
    Hanif J; Iqbal K; Perveen F; Arif A; Iqbal RN; Jameel F; Hanif K; Seemab A; Khan AY; Ahmed M
    Cureus; 2021 Nov; 13(11):e20038. PubMed ID: 34993024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Low-dose Suprachoroidal Triamcinolone Acetonide Injection in Macular Edema Secondary to Noninfectious Posterior Uveitis.
    Anand A; Sinha S; Gupta A; Shree S; Ambasta A; Sinha BP; Azad R
    Middle East Afr J Ophthalmol; 2023; 30(1):6-12. PubMed ID: 38435103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety.
    Yeh S; Ciulla T
    Am J Manag Care; 2023 Feb; 29(2 Suppl):S19-S28. PubMed ID: 36787524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triamcinolone Acetonide Suprachoroidal Injectable Suspension for Uveitic Macular Edema: Integrated Analysis of Two Phase 3 Studies.
    Yeh S; Henry CR; Kapik B; Ciulla TA
    Ophthalmol Ther; 2023 Feb; 12(1):577-591. PubMed ID: 36399237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triamcinolone acetonide injectable suspension for suprachoroidal use in the treatment of macular edema associated with uveitis.
    Thomas J; Kim L; Albini T; Yeh S
    Expert Rev Ophthalmol; 2022; 17(3):165-173. PubMed ID: 36060305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach.
    Habot-Wilner Z; Noronha G; Wykoff CC
    Acta Ophthalmol; 2019 Aug; 97(5):460-472. PubMed ID: 30702218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
    Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
    Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suprachoroidal Triamcinolone Injection in Posterior Scleritis: A Case Report.
    Rujkorakarn P; Zhou A; Babiker F; Chang PY
    Ocul Immunol Inflamm; 2023 Jul; ():1-4. PubMed ID: 37450640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of suprachoroidal triamcinolone injection in horses with poorly responsive equine recurrent uveitis.
    Gagnon NA; Hartley C; Gilger BC
    Vet Ophthalmol; 2021 May; 24(3):308-312. PubMed ID: 33788369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study.
    Barakat MR; Wykoff CC; Gonzalez V; Hu A; Marcus D; Zavaleta E; Ciulla TA
    Ophthalmol Retina; 2021 Jan; 5(1):60-70. PubMed ID: 32829027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
    Jaffe GJ; Pavesio CE;
    Ophthalmology; 2020 Oct; 127(10):1395-1404. PubMed ID: 32624244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
    Suhler EB; Jaffe GJ; Fortin E; Lim LL; Merrill PT; Dick AD; Brezin AP; Nguyen QD; Thorne JE; Van Calster J; Cimino L; Adan A; Goto H; Kaburaki T; Kramer M; Vitale AT; Kron M; Song AP; Liu J; Pathai S; Douglas KM; Schlaen A; Muccioli C; Van Velthoven MEJ; Zierhut M; Rosenbaum JT
    Ophthalmology; 2021 Jun; 128(6):899-909. PubMed ID: 33157077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial.
    Shah M; Albini T; Nguyen Q; Wykoff C; Barakat M; Khurana RN; Kapik B; Ciulla TA
    Ocul Immunol Inflamm; 2024 Jan; ():1-8. PubMed ID: 38194432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.